Total Payments
$31,884
2024 Payments
$11,000
Companies
3
Transactions
36
Medicare Patients
1,206
Medicare Billing
$108,816
Payment Breakdown by Category
Other$31,250 (98.0%)
Travel$372.86 (1.2%)
Food & Beverage$261.15 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $16,500 | 12 | 51.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,750 | 11 | 46.3% |
| Travel and Lodging | $372.86 | 4 | 1.2% |
| Food and Beverage | $261.15 | 9 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organon Llc | $20,761 | 19 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $11,086 | 16 | $0 (2021) |
| Saol Therapeutics Inc. | $37.02 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,000 | 8 | Organon Llc ($11,000) |
| 2023 | $2,850 | 5 | Organon LLC ($2,850) |
| 2022 | $2,787 | 3 | Organon LLC ($2,787) |
| 2021 | $8,772 | 8 | Merck Sharp & Dohme Corporation ($4,647) |
| 2020 | $37.02 | 1 | Saol Therapeutics Inc. ($37.02) |
| 2019 | $5,439 | 10 | Merck Sharp & Dohme Corporation ($5,439) |
| 2018 | $1,000 | 1 | Merck Sharp & Dohme Corporation ($1,000) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Organon Llc | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| 11/14/2024 | Organon Llc | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 07/18/2024 | Organon Llc | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| 07/18/2024 | Organon Llc | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 07/15/2024 | Organon Llc | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| 07/15/2024 | Organon Llc | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 03/28/2024 | Organon Llc | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| 03/28/2024 | Organon Llc | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 10/19/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 10/03/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: ETONOGESTREL | ||||||
| 09/21/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 09/13/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $45.97 | General |
| Category: ETONOGESTREL | ||||||
| 09/13/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: ETONOGESTREL | ||||||
| 11/17/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 11/10/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $36.53 | General |
| Category: ETONOGESTREL | ||||||
| 09/22/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 12/23/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 07/15/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 07/12/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 05/06/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: WOMENS HEALTH | ||||||
| 05/06/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Travel and Lodging | Cash or cash equivalent | $126.60 | General |
| Category: WOMENS HEALTH | ||||||
| 04/15/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 03/31/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: WOMENS HEALTH | ||||||
| 01/22/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 03/04/2020 | Saol Therapeutics Inc. | Lioresal (baclofen) (Drug), Dysport | Food and Beverage | In-kind items and services | $37.02 | General |
| Category: Severe Spasticity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 244 | 346 | $62,472 | $24,247 |
| 2022 | 10 | 286 | 387 | $73,029 | $27,507 |
| 2021 | 13 | 376 | 505 | $75,375 | $31,291 |
| 2020 | 9 | 300 | 421 | $60,451 | $25,771 |
Total Patients
1,206
Total Services
1,659
Medicare Billing
$108,816
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 93 | $13,370 | $5,425 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 59 | $14,476 | $4,332 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $6,440 | $3,357 | 52.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 25 | $8,563 | $3,070 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 38 | $6,574 | $2,271 | 34.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 25 | $5,330 | $2,199 | 41.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 27 | 30 | $4,442 | $1,816 | 40.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 16 | 16 | $2,160 | $1,191 | 55.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $525.00 | $423.54 | 80.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 17 | $592.00 | $161.84 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 99 | $23,385 | $7,377 | 31.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 66 | $13,764 | $5,089 | 37.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $11,053 | $3,898 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $5,562 | $3,316 | 59.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 55 | $7,260 | $2,862 | 39.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 37 | 37 | $5,143 | $1,944 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 29 | $4,765 | $1,506 | 31.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 15 | 15 | $1,575 | $1,046 | 66.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $432.00 | $424.98 | 98.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 15 | $90.00 | $44.43 | 49.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 116 | $26,332 | $8,711 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 95 | $11,400 | $5,130 | 45.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 36 | 36 | $7,416 | $4,509 | 60.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 32 | $5,600 | $2,530 | 45.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $5,525 | $2,504 | 45.3% |
About Dr. Terrence Truong, M.D
Dr. Terrence Truong, M.D is a Family Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508805300.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terrence Truong, M.D has received a total of $31,884 in payments from pharmaceutical and medical device companies, with $11,000 received in 2024. These payments were reported across 36 transactions from 3 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a medical education program" ($16,500).
As a Medicare-enrolled provider, Truong has provided services to 1,206 Medicare beneficiaries, totaling 1,659 services with total Medicare billing of $108,816. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Oklahoma City, OK
- Active Since 06/06/2006
- Last Updated 04/05/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1508805300
Products in Payments
- NEXPLANON (Drug) $22,222
- Nexplanon (Drug) $4,125
- Lioresal (baclofen) (Drug) $37.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oklahoma City
Melinda Cail, M.d, M.D
Family Medicine — Payments: $96,253
Family Medicine $96,253
Dr. Carl Griffin, M.d, M.D
Family Medicine — Payments: $58,692
Family Medicine $58,692
Dr. John Pittman, M.d, M.D
Family Medicine — Payments: $58,571
Family Medicine $58,571
Dr. Tyler Phillips, Md, MD
Family Medicine — Payments: $33,490
Family Medicine $33,490
Jonathan Knox, D.o, D.O
Family Medicine — Payments: $23,297
Family Medicine $23,297
Stanley Corley, M.d, M.D
Family Medicine — Payments: $19,788
Family Medicine $19,788